Donnie McGrath is the founder of Belenos Biosciences. Belenos Biosciences has raised $48M in total funding. Latest round: Series A. Backed by OrbiMed.
Donnie McGrath is the Chief Executive Officer of Belenos Biosciences Inc., a New York-based biotech company focused on long-lasting bispecific antibodies for inflammatory diseases. He previously served as Executive Chairman and President at BioShin Ltd. and is a Venture Partner at OrbiMed Advisors Private Equity. McGrath led Belenos through its formation in 2024 and its $48 million Series A equity round.
Full founder directory · Investor directory · Company funding database · Fundraising library